Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 06, 2017 Filed Dec 8, 2017 22:29 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 3 | $54.96 | $164.87 |
DisclosureSEC source: 0001179110-17-015160 · edgar.xml · nonDerivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,151,331 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:29 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 428 | $54.95 | $23,518.60 |
DisclosureSEC source: 0001179110-17-015160 · edgar.xml · nonDerivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,151,334 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:29 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 200 | $54.95 | $10,989.00 |
DisclosureSEC source: 0001179110-17-015160 · edgar.xml · nonDerivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,151,762 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:29 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 1,200 | $54.94 | $65,928.00 |
DisclosureSEC source: 0001179110-17-015160 · edgar.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,151,962 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:29 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 1,600 | $54.93 | $87,888.00 |
DisclosureSEC source: 0001179110-17-015160 · edgar.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,153,162 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:29 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 392 | $54.93 | $21,530.60 |
DisclosureSEC source: 0001179110-17-015160 · edgar.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,154,762 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:29 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 3,300 | $54.92 | $181,236.00 |
DisclosureSEC source: 0001179110-17-015160 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,155,154 Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 22:29 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 103 | $54.92 | $5,656.25 |
DisclosureSEC source: 0001179110-17-015160 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,158,454 Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 22:08 UTC |
Bracken Sharon JSenior Vice President
|
SaleCommon shares without par value | 600 | $56.13 | $33,675.00 |
DisclosureSEC source: 0001179110-17-014780 · edgar.xml · nonDerivative · entry 2 Bracken Sharon J · CIK 0001710778 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,018 Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 22:08 UTC |
Bracken Sharon JSenior Vice President
|
SaleCommon shares without par value | 1,588 | $56.12 | $89,120.15 |
DisclosureSEC source: 0001179110-17-014780 · edgar.xml · nonDerivative · entry 1 Bracken Sharon J · CIK 0001710778 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,618 Read SEC document |
| November 22, 2017 Filed Nov 22, 2017 22:15 UTC |
Wellisch Alejandro DSenior Vice President
|
SaleCommon shares without par value | 453 | $55.87 | $25,306.85 |
DisclosureSEC source: 0001179110-17-014577 · edgar.xml · nonDerivative · entry 3 Wellisch Alejandro D · CIK 0001717526 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,803 Read SEC document |
| November 22, 2017 Filed Nov 22, 2017 22:15 UTC |
Wellisch Alejandro DSenior Vice President
|
SaleCommon shares without par value | 1,000 | $55.86 | $55,861.00 |
DisclosureSEC source: 0001179110-17-014577 · edgar.xml · nonDerivative · entry 2 Wellisch Alejandro D · CIK 0001717526 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,256 Read SEC document |
| November 22, 2017 Filed Nov 22, 2017 22:15 UTC |
Wellisch Alejandro DSenior Vice President
|
SaleCommon shares without par value | 700 | $55.86 | $39,102.07 |
DisclosureSEC source: 0001179110-17-014577 · edgar.xml · nonDerivative · entry 1 Wellisch Alejandro D · CIK 0001717526 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,256 Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:16 UTC |
Blaser Brian J.Executive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 6,333 | $0.00 Strike: $23.23 | $0.00 |
DisclosureSEC source: 0001179110-17-014379 · edgar.xml · derivative · entry 14 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 6,333 shares Expires 2020-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:16 UTC |
Blaser Brian J.Executive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,233 | $0.00 Strike: $26.19 | $0.00 |
DisclosureSEC source: 0001179110-17-014379 · edgar.xml · derivative · entry 13 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 3,233 shares Expires 2020-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:16 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 10,287 | $55.54 | $571,288.55 |
DisclosureSEC source: 0001179110-17-014379 · edgar.xml · nonDerivative · entry 12 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,854 Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:16 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 200 | $55.53 | $11,106.42 |
DisclosureSEC source: 0001179110-17-014379 · edgar.xml · nonDerivative · entry 11 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,141 Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:16 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 200 | $55.53 | $11,106.40 |
DisclosureSEC source: 0001179110-17-014379 · edgar.xml · nonDerivative · entry 10 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,341 Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:16 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 713 | $55.53 | $39,593.60 |
DisclosureSEC source: 0001179110-17-014379 · edgar.xml · nonDerivative · entry 9 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,541 Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:16 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 900 | $55.53 | $49,977.09 |
DisclosureSEC source: 0001179110-17-014379 · edgar.xml · nonDerivative · entry 8 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,254 Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:16 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 2,000 | $55.53 | $111,060.00 |
DisclosureSEC source: 0001179110-17-014379 · edgar.xml · nonDerivative · entry 7 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,154 Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:16 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 1,922 | $55.57 | $106,795.93 |
DisclosureSEC source: 0001179110-17-014379 · edgar.xml · nonDerivative · entry 6 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,154 Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:16 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 3,944 | $55.57 | $219,168.08 |
DisclosureSEC source: 0001179110-17-014379 · edgar.xml · nonDerivative · entry 5 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,076 Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:16 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 1,000 | $55.57 | $55,571.00 |
DisclosureSEC source: 0001179110-17-014379 · edgar.xml · nonDerivative · entry 4 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,020 Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:16 UTC |
Blaser Brian J.Executive Vice President
|
SaleCommon shares without par value | 2,700 | $55.58 | $150,052.50 |
DisclosureSEC source: 0001179110-17-014379 · edgar.xml · nonDerivative · entry 3 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,020 Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:16 UTC |
Blaser Brian J.Executive Vice President
|
Exercise / conversionCommon shares without par value | 6,333 | $23.23 | $147,102.92 |
DisclosureSEC source: 0001179110-17-014379 · edgar.xml · nonDerivative · entry 2 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 22:16 UTC |
Blaser Brian J.Executive Vice President
|
Exercise / conversionCommon shares without par value | 3,233 | $26.19 | $84,665.48 |
DisclosureSEC source: 0001179110-17-014379 · edgar.xml · nonDerivative · entry 1 Blaser Brian J · CIK 0001492289 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 22:06 UTC |
Salvadori Daniel Gesua SiveExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 71,157 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-17-014210 · edgar.xml · derivative · entry 3 Salvadori Daniel Gesua Sive · CIK 0001620564 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,313 Underlying: Common shares · 71,157 shares Expires 2026-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 22:06 UTC |
Salvadori Daniel Gesua SiveExecutive Vice President
|
SaleCommon shares without par value | 71,157 | $55.00 | $3,913,635.00 |
DisclosureSEC source: 0001179110-17-014210 · edgar.xml · nonDerivative · entry 2 Salvadori Daniel Gesua Sive · CIK 0001620564 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,798 Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 22:06 UTC |
Salvadori Daniel Gesua SiveExecutive Vice President
|
Exercise / conversionCommon shares without par value | 71,157 | $38.40 | $2,732,428.80 |
DisclosureSEC source: 0001179110-17-014210 · edgar.xml · nonDerivative · entry 1 Salvadori Daniel Gesua Sive · CIK 0001620564 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 21:03 UTC |
Salvadori Daniel Gesua SiveExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 28,319 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013439 · edgar.xml · derivative · entry 6 Salvadori Daniel Gesua Sive · CIK 0001620564 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,798 Underlying: Common shares · 28,319 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 21:03 UTC |
Salvadori Daniel Gesua SiveExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 34,142 | $0.00 Strike: $42.08 | $0.00 |
DisclosureSEC source: 0001179110-17-013439 · edgar.xml · derivative · entry 5 Salvadori Daniel Gesua Sive · CIK 0001620564 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 34,142 shares Expires 2024-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 21:03 UTC |
Salvadori Daniel Gesua SiveExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 34,142 | $0.00 Strike: $42.08 | $0.00 |
DisclosureSEC source: 0001179110-17-013439 · edgar.xml · derivative · entry 4 Salvadori Daniel Gesua Sive · CIK 0001620564 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,142 Underlying: Common shares · 34,142 shares Expires 2024-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 21:03 UTC |
Salvadori Daniel Gesua SiveExecutive Vice President
|
SaleCommon shares without par value | 96,603 | $56.21 | $5,430,054.63 |
DisclosureSEC source: 0001179110-17-013439 · edgar.xml · nonDerivative · entry 3 Salvadori Daniel Gesua Sive · CIK 0001620564 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,798 Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 21:03 UTC |
Salvadori Daniel Gesua SiveExecutive Vice President
|
Exercise / conversionCommon shares without par value | 28,319 | $47.00 | $1,330,993.00 |
DisclosureSEC source: 0001179110-17-013439 · edgar.xml · nonDerivative · entry 2 Salvadori Daniel Gesua Sive · CIK 0001620564 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 21:03 UTC |
Salvadori Daniel Gesua SiveExecutive Vice President
|
Exercise / conversionCommon shares without par value | 68,284 | $42.08 | $2,873,390.72 |
DisclosureSEC source: 0001179110-17-013439 · edgar.xml · nonDerivative · entry 1 Salvadori Daniel Gesua Sive · CIK 0001620564 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 21:17 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 147 | $53.36 | $7,843.92 |
DisclosureSEC source: 0001179110-17-013009 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,502 Underlying: Common shares · 147 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 21:18 UTC |
Stratton John GDirector
|
GrantStock Equivalent Units · Derivative | 590 | $53.36 | $31,482.40 |
DisclosureSEC source: 0001179110-17-013010 · edgar.xml · derivative · entry 1 Stratton John G · CIK 0001385262 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590 Underlying: Common shares · 590 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 21:18 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 618 | $53.36 | $32,976.48 |
DisclosureSEC source: 0001179110-17-013011 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,902 Underlying: Common shares · 618 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 26, 2017 Filed Sep 28, 2017 21:13 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 28,319 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001179110-17-012749 · edgar.xml · derivative · entry 6 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,117 Underlying: Common shares · 28,319 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 26, 2017 Filed Sep 28, 2017 21:13 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 34,141 | $0.00 Strike: $42.08 | $0.00 |
DisclosureSEC source: 0001179110-17-012749 · edgar.xml · derivative · entry 5 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,284 Underlying: Common shares · 34,141 shares Expires 2024-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 26, 2017 Filed Sep 28, 2017 21:13 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
Tax withholdingCommon shares without par value | 5,487 | $52.61 | $288,671.07 |
DisclosureSEC source: 0001179110-17-012749 · edgar.xml · nonDerivative · entry 4 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,798 Read SEC document |
| September 26, 2017 Filed Sep 28, 2017 21:13 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
SaleCommon shares without par value | 62,460 | $52.95 | $3,307,257.00 |
DisclosureSEC source: 0001179110-17-012749 · edgar.xml · nonDerivative · entry 3 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,285 Read SEC document |
| September 26, 2017 Filed Sep 28, 2017 21:13 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
Exercise / conversionCommon shares without par value | 28,319 | $47.00 | $1,330,993.00 |
DisclosureSEC source: 0001179110-17-012749 · edgar.xml · nonDerivative · entry 2 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 26, 2017 Filed Sep 28, 2017 21:13 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
Exercise / conversionCommon shares without par value | 34,141 | $42.08 | $1,436,653.28 |
DisclosureSEC source: 0001179110-17-012749 · edgar.xml · nonDerivative · entry 1 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2017 Filed Sep 26, 2017 21:47 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 22,000 | $0.00 Strike: $27.03 | $0.00 |
DisclosureSEC source: 0001179110-17-012721 · edgar.xml · derivative · entry 22 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 22,000 shares Expires 2022-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 22, 2017 Filed Sep 26, 2017 21:47 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 17,300 | $0.00 Strike: $22.39 | $0.00 |
DisclosureSEC source: 0001179110-17-012721 · edgar.xml · derivative · entry 21 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 17,300 shares Expires 2021-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 22, 2017 Filed Sep 26, 2017 21:47 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 13,400 | $0.00 Strike: $26.19 | $0.00 |
DisclosureSEC source: 0001179110-17-012721 · edgar.xml · derivative · entry 20 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 13,400 shares Expires 2020-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 22, 2017 Filed Sep 26, 2017 21:47 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 1,200 | $52.04 | $62,449.20 |
DisclosureSEC source: 0001179110-17-012721 · edgar.xml · nonDerivative · entry 15 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,339 Read SEC document |
| September 22, 2017 Filed Sep 26, 2017 21:47 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 1,200 | $52.04 | $62,448.00 |
DisclosureSEC source: 0001179110-17-012721 · edgar.xml · nonDerivative · entry 14 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,539 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.